Protocol T Extension Results

Related

• 

  First Time Results of VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy

  Omer Trivizki, MD, MBA

  Updates from the Field

  2025

• 

  Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema

  Chirag D. Jhaveri, MD, FASRS

  Annual Meeting Talks

  2022

• 

  The Evolving Treatment of Proliferative Diabetic Retinopathy: The Diabetic Retinopathy Study to the DRCR Protocol S

  Timothy W. Olsen, MD

  Webinars and Journal Clubs

  2016